Anticoagulants

You have accessRestricted Access
IgA Nephropathy in Elderly Patients
Angel M. Sevillano, Monserrat Diaz, Fernando Caravaca-Fontán, Clara Barrios, Carmen Bernis, Jimena Cabrera, Jesus Calviño, Lorena Castillo, Carmen Cobelo, Patricia Delgado-Mallén, Mario Espinosa, Gema Fernandez-Juarez, Maria Jose Fernandez-Reyes, Rosa Garcia-Osuna, Patricia Garcia, Marian Goicoechea, Fayna Gonzalez-Cabrera, Diomaris A. Guzmán, Manuel Heras, Guillermo Martín-Reyes, Alberto Martinez, Teresa Olea, Jessy Korina Peña, Luis F. Quintana, Cristina Rabasco, Katia López Revuelta, Lida Rodas, Nuria Rodriguez-Mendiola, Eva Rodriguez, Luz San Miguel, Maria Dolores Sanchez de la Nieta, Amir Shabaka, Milagros Sierra, Alfonso Valera, Mercedes Velo, Eduardo Verde, Jose Ballarin, Oscar Noboa, Juan Antonio Moreno, Eduardo Gutiérrez, Manuel Praga and on behalf of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)

CJASN July 2019, CJN.13251118; DOI: https://doi.org/10.2215/CJN.13251118

Add to Selected Citations
Open Access
Anticoagulant-Related Nephropathy
Richard J. Glassock

CJASN June 2019, 14 (6) 935-937; DOI: https://doi.org/10.2215/CJN.02470319

Add to Selected Citations
You have accessRestricted Access
Correction
CJASN May 2019, 14 (5) 750; DOI: https://doi.org/10.2215/CJN.02630319

Add to Selected Citations
Open Access
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease
Nishank Jain and Robert F. Reilly

CJASN February 2019, 14 (2) 278-287; DOI: https://doi.org/10.2215/CJN.02170218

Add to Selected Citations
Open Access
Clinical Pharmacogenomics
Solomon M. Adams, Karryn R. Crisamore and Philip E. Empey

CJASN October 2018, 13 (10) 1561-1571; DOI: https://doi.org/10.2215/CJN.02730218

Add to Selected Citations
You have accessRestricted Access
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams

CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro
Peter A. McCullough, Timothy Ball, Katy Mathews Cox and Manish D. Assar

CJASN November 2016, 11 (11) 2079-2084; DOI: https://doi.org/10.2215/CJN.02680316

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2
Charles A. Herzog

CJASN November 2016, 11 (11) 2095-2096; DOI: https://doi.org/10.2215/CJN.09470916

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction
Paul M. Palevsky

CJASN November 2016, 11 (11) 2078; DOI: https://doi.org/10.2215/CJN.09700916

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1
Nisha Bansal

CJASN November 2016, 11 (11) 2093-2094; DOI: https://doi.org/10.2215/CJN.08610816

Add to Selected Citations

Main menu

User menu

Search

Anticoagulants

About

Author Information

More information